- $945.25m
- $1.20bn
- $310.46m
- 87
- 85
- 87
- 98
Annual cashflow statement for Innoviva, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 191 | 294 | 369 | 220 | 180 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 7.62 | -40.6 | -78.4 | -69.9 | -54 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 3.1 | -14.3 | -16.9 | 6.87 | -24.8 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 257 | 313 | 364 | 202 | 141 |
| Capital Expenditures | -0.012 | -0.013 | 0 | -0.067 | -0.411 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -18 | -315 | 43.7 | -56.6 | -66.3 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | -18 | -315 | 43.7 | -56.6 | -66.8 |
| Financing Cash Flow Items | -10.6 | -30.1 | -59.5 | -114 | 0 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -23.8 | -29.8 | -452 | -55.6 | -172 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 216 | -31.6 | -45 | 89.5 | -97.5 |